In vitro 3D cell culture models have emerged as a bridge between traditional 2D cell culture and in vivo animal models. With the advancement of 3D cell culture technologies, both healthy physiological models and disease states can be emulated in vitro. In this session, Dr. Lim Sei Hien from AIM Biotech will introduce the organ-on-chip solution that AIM Biotech offers and discuss how the Opentrons OT-2 helps to scale up assays for drug discovery and cell biology research.

Sign up to watch this 45-minute webinar to learn about:

• AIM Biotech’s microfluidic technology and humanized approach to 3D tissue culture
• Therapeutic Areas, Assays and Applications where AIM Biotech’s idenTx and organiX platforms provide more predictive data than conventional 2D approaches
• How the Opentrons OT-2 enables researchers to easily maximize the throughput potential of idenTx and organiX for their applications

Who Should Watch:

• Drug Discovery & Development Scientists
• Clinical Diagnostics Developers 
• Group Leaders or Research Directors
• Medical & Academic Researchers
• Automation Specialists or Biomedical Engineers

Subject to your consent given above, by clicking on "GET THE WEBINAR", Opentrons and AIM Biotech may share your personal information to communicate with you for marketing purposes, including information about this topic, promotional offers and news. This use of your personal information is an exception to our Privacy Policy.

Lim Sei Hien, PhD

Applications Development Manager, AIM Biotech

Lim Sei Hien is the Applications Development Manager at AIM Biotech. Prior to joining AIM Biotech’s Team, he focused on developing neovascularization strategies for tissue repair and regeneration. Sei Hien has a wealth of experience in establishing cell-based functional models in microfluidics for research applications. Sei Hien received his Ph.D. in Bioengineering from the National University of Singapore.

Originally Aired 11/14/22